Carna’s Next-Gen Mobility Shift Assay (MSA) System supporting kinase drug discovery is now operational with scientific and budget friendly benefits!
Valid Now through November 27, 2024
Don’t miss these one-time opportunities!
Offer 1
30% discount for reciprocal biochemical or cellular studies!
>> Step 1: Evaluate compounds using either our biochemical or cell-based assay services.
>> Step 2: Receive 30% discount on service order using same compounds in the reciprocal service (biochemical/cellular).
Assay services included in this offer:
Mobility Shift Assay(MSA)/IMAP™ Services & ADP-Glo™ Assay Services
and
NanoBRET™ TE Intracellular Kinase Assay Services
Offer 2
Zero Cost follow-up IC50 determinations!
>>Step 1: Evaluate compounds in our biochemical % inhibition service.
>>Step 2: Receive ZERO COST IC50 follow up studies using same compounds.
[Offer Conditions]
1. With a % inhibition order against 50 or more kinase targets, receive complimentary follow-up IC50 determinations against up to 4 kinase targets* (for each screened compound).
2. With a % inhibition order against 100 or more kinase targets, receive complimentary follow-up IC50 determinations against up to 8 kinase targets* (for each screened compound).
*The kinase targets selected for free follow-up IC50 determination studies must be those where the compound has a >50 % inhibitory effect.
Study report comes with Carna’s original Kinome Map, on which your data is graphically displayed for easy assessment of specificity and activity.
For details, please check here contact us at info@carnabio.com or get in touch with our local representatives!!